Amid a backdrop of mixed global market performances and economic signals, the Hong Kong market has shown resilience with strategic movements in various sectors. As investors navigate through these complex conditions, companies with high insider ownership on the SEHK stand out as potentially strong candidates due to their alignment of interests between shareholders and management. Top 10 Growth Companies With High Insider Ownership In Hong Kong Name Insider Ownership Earnings Growth iDreamSky Technology Holdings (SEHK:1119) 20.2% 104.1% Pacific Textiles Holdings (SEHK:1382) 11.2% 37.7% Tian Tu Capital (SEHK:1973) 34% 70.5% Fenbi (SEHK:2469) 30.6% 42.8% Adicon Holdings (SEHK:9860) 22.4% 28.3% DPC Dash (SEHK:1405) 38.2% 91.4% Zylox-Tonbridge Medical Technology (SEHK:2190) 18.7% 79.3% Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) 13.9% 100.1% Beijing Airdoc Technology (SEHK:2251) 28.7% 83.9% Ocumension Therapeutics (SEHK:1477) 23.3% 93.7% Click here to see the full list of 54 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener. Here's a peek at a few of the choices from the screener. Meitu Simply Wall St Growth Rating: ★★★★☆☆ Overview: Meitu, Inc. is an investment holding company that develops image, video, and design products to promote industry digitalization with beauty-related solutions in China and globally, with a market capitalization of approximately HK$11.97 billion. Operations: The company generates revenue primarily from its Internet Business segment, totaling CN¥2.70 billion. Insider Ownership: 36.6% Earnings Growth Forecast: 28.6% p.a. Meitu, a growth company in Hong Kong with high insider ownership, has shown promising developments despite some challenges. Recently, the company projected a significant increase in net profit for the first half of 2024, reflecting robust operational performance. However, it faces low return on equity forecasts and no substantial insider buying recently. Notably, its revenue and earnings growth are expected to outpace the local market significantly. Changes in executive roles and corporate bylaws underscore ongoing strategic adjustments to bolster governance and market positioning. Unlock comprehensive insights into our analysis of Meitu stock in this growth report. The valuation report we've compiled suggests that Meitu's current price could be inflated. SEHK:1357 Earnings and Revenue Growth as at Jul 2024 Xiamen Yan Palace Bird's Nest Industry Simply Wall St Growth Rating: ★★★★☆☆ Overview: Xiamen Yan Palace Bird's Nest Industry Co., Ltd. focuses on the research, development, production, and marketing of edible bird’s nest products within the People’s Republic of China and has a market capitalization of approximately HK$6.87 billion. Operations: The company generates revenue through various segments, including CN¥16.75 million from sales to online distributors, CN¥509.04 million from sales to offline distributors, CN¥824.40 million from direct sales to online customers, CN¥351.17 million from direct sales to offline customers, and CN¥262.89 million from direct sales to e-commerce platforms. Insider Ownership: 26.7% Earnings Growth Forecast: 14.8% p.a. Xiamen Yan Palace Bird's Nest Industry, a growth-oriented firm in Hong Kong with high insider ownership, forecasts revenue growth of 12.5% annually, surpassing the local market's 7.4%. Despite a projected decrease in net profit by up to 50% for the first half of 2024 due to tough conditions, its revenue benefits from strong online sales. The company also maintains a solid return on equity forecast at 27.3% within three years and continues to pay dividends, recently approving RMB 2.15 per ten shares. Navigate through the intricacies of Xiamen Yan Palace Bird's Nest Industry with our comprehensive analyst estimates report here. Our valuation report unveils the possibility Xiamen Yan Palace Bird's Nest Industry's shares may be trading at a premium. SEHK:1497 Earnings and Revenue Growth as at Jul 2024 Adicon Holdings Simply Wall St Growth Rating: ★★★★★☆ Overview: Adicon Holdings Limited is a company that operates medical laboratories in the People's Republic of China, with a market capitalization of approximately HK$6.99 billion. Operations: The company generates revenue primarily from its healthcare facilities and services, totaling CN¥3.30 billion. Insider Ownership: 22.4% Earnings Growth Forecast: 28.3% p.a. Adicon Holdings, a Hong Kong-based company with high insider ownership, is anticipated to see its earnings grow by 28.3% annually, outpacing the local market's 11.3%. Although profit margins have dipped from 14% to 7.1%, revenue growth remains robust at 14.3% per year, double the market average of 7.4%. The firm recently initiated a share repurchase program, enhancing shareholder value by potentially increasing net asset value and earnings per share through the buyback of up to 10% of its issued capital. Delve into the full analysis future growth report here for a deeper understanding of Adicon Holdings. The analysis detailed in our Adicon Holdings valuation report hints at an inflated share price compared to its estimated value. SEHK:9860 Earnings and Revenue Growth as at Jul 2024 Key Takeaways Take a closer look at our Fast Growing SEHK Companies With High Insider Ownership list of 54 companies by clicking here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SEHK:1357 SEHK:1497 and SEHK:9860. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
High Insider Ownership Growth Companies On SEHK To Watch In July 2024
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...